Junyue Fang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Optimisation and validation of capture mNGS for predicting antimicrobial resistance.
Journal: EBioMedicine
Published: July 07, 2025
Co-Delivery of Chemotherapy and Anti-Angiogenic Lipid via DPPA-LNPs Potentiates Anti-PD-1 Immunotherapy.
Journal: International journal of nanomedicine
Published: June 04, 2025
Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways.
Journal: Theranostics
Published: April 01, 2025
Delivery of an ERK inhibitor using bioactive lipid nanoparticles reduces angiogenesis and prevents oral squamous cell carcinoma development.
Journal: Journal of nanobiotechnology
Published: March 01, 2025
Dual-Responsive Immunomodulatory RNAi Nanoplatform for Effective Immune Checkpoint Blockade and Enhanced Cancer Immunotherapy.
Journal: Advanced healthcare materials
Published: February 05, 2025
Bioactive Nanotherapeutic Ultrasound Contrast Agent for Concurrent Breast Cancer Ultrasound Imaging and Treatment.
Journal: Advanced healthcare materials
Published: April 19, 2024
Aberrant expression of T cell activation markers and upregulation of Tregs in bone marrow and peripheral blood in acute myeloid leukemia patients.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 08, 2023
Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China.
Journal: Mycoses
Published: January 25, 2023
Advances in pathogenesis and nanoparticles (NPs)-mediated treatment of psoriasis.
Journal: Frontiers in immunology
Published: November 04, 2022
Last Updated: 09/26/2026